Channels - Cardiovascular Disease, Cancer and Dementia in Diabetes: 20‐Year Trends Will Necessitate New Treatment Priorities :: FRELIP Discovery

Similar Items: Cardiovascular Disease, Cancer and Dementia in Diabetes: 20‐Year Trends Will Necessitate New Treatment Priorities

Quick Look
Clinical Characteristics of Diabetic Cardiovascular Autonomic Neuropathy in Korean Individuals With Type 2 Diabetes
Quick Look
Polygenic risk score refines cardiovascular disease risk in individuals with type 2 diabetes at borderline or intermediate risk
Quick Look
Diabetic foot ulcer‐related amputation is associated with twofold increased risk of cardiovascular disease: A Korean National Health Information Database Study
Quick Look
Trends and disparities in valvular heart disease–related mortality among adults with diabetes mellitus in the United States: 1999–2024
Quick Look
Technology in Diabetes: A Year in Review
Quick Look
Metabolic dysfunction–associated steatotic liver disease and cardiovascular disease: Emerging insights into the liver–heart axis
Quick Look
Resistance Training in Cardiovascular Diseases: A Review on Its Effectiveness in Controlling Risk Factors
Quick Look
Podcast Episode 3: How Can Physicians Work Collaboratively to Improve Cardiovascular Outcomes in Patients with Type 2 Diabetes?
Quick Look
Prevalence of diagnostic Mendelian kidney disease variants in type 2 diabetes with and without diabetic kidney disease
Quick Look
Low Subjective Cardiovascular Disease Risk Perceptions among Hypertensive Patients in Addis Ababa, Ethiopia
Quick Look
Semaglutide and Cardiovascular Outcomes in People with Type 2 Diabetes: A SUSTAIN-6 Post Hoc Analysis by Weight Loss Category
Quick Look
Do the treatment selection factors emphasized in clinical guidelines—Chronic kidney disease, cardiovascular disease, and heart failure—contribute to the risk of urinary tract infections during the administration of sodium‐glucose cotransporter‐2 inhibitors?
Quick Look
Prevalence and treatment of mitochondrial diabetes in Southwest Finland
Quick Look
Aldosterone Synthase Inhibition in Diabetes and Cardiorenal Metabolic Disease
Quick Look
Intensified multifactorial intervention leads to long‐term benefit on kidney outcomes in advanced diabetic kidney disease: A 10‐year follow‐up of the DNETT‐Japan trial
Quick Look
Population attributable fraction of cardiovascular disease, coronary heart disease, and stroke associated with insufficient non-occupational physical activity in Iranian adults: findings from the STEPS 2021 survey
Quick Look
Trends in the incidence and prevalence of thyroid dysfunction over 18 years and projections for 2030: the Tehran thyroid study
Quick Look
The Role of the Notch1 Signaling Pathway in the Pathogenesis and Treatment of Diabetic Foot: A Review
Quick Look
Sestrin-2: a new biomarker for type 2 Diabetes Mellitus and Insulin resistance
Quick Look
Developing a machine learning model to predict renal function decline within three years using one‐year longitudinal data in patients with type 2 diabetes
Quick Look
National trends and disparities in cardiomyopathy-related mortality among individuals with diabetes mellitus in the United States: A retrospective observational study from 1999 to 2019
Quick Look
Implementing SGLT2 Inhibitor Therapy in Line with the New NICE Guidelines for Type 2 Diabetes Management
Quick Look
Global burden of metabolic dysfunction-associated steatotic liver disease attributable to tobacco, 1990–2023, and projected trends to 2038
Quick Look
Risk of biliary diseases in patients with type 2 diabetes or obesity treated with tirzepatide: A critical appraisal